INDIANAPOLIS, Oct. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a pivotal Phase III study of Cialis® (tadalafil) tablets 5 mg for once daily use met its co-primary ...

INDIANAPOLIS, July 16, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that study results published in the Journal of Sexual Medicine showed a greater percentage of men who had ...

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.

Eli Lilly and Company announced that a pivotal phase III study of Cialis (tadalafil) tablets 5 mg for once daily use met its co-primary endpoints, significantly improving measures of both erectile ...

Pivotal studies support tadalafil for the treatment of benign prostatic hyperplasia and the treatment of both benign prostatic hyperplasia and erectile dysfunction in patients with both conditions.

Like Viagra, Stendra and Levitra, Cialis is highly effective as a treatment for ED. But no medication has a 100 percent success rate, and Cialis is no exception. Even after you take Cialis, you could ...

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has approved Cialis (tadalafil) tablets for once daily use for the treatment of men who have both erectile dysfunction ...

A new phase 3 study has found that tadalafil (Cialis) 5 mg once daily co-administered with finasteride significantly improved scores on the International Prostate Symptom Score compared with ...

Men with prostate cancer who are treated with radiation therapy shouldn't count on using the drug tadalafil (brand name: Cialis) to prevent erectile dysfunction, according to a study published today ...